Lightlake Therapeutics and NIH partner to develop intranasal naloxone for opioid overdose Aug. 22, 2013 No Comments
Atlantic Pharmaceuticals completes pre-IND meeting with FDA for abuse-deterrent hydrocodone Aug. 16, 2013 No Comments
Orexo begins dosing in two trials evaluating early and long-term treatment with Zubsolv Aug. 8, 2013 No Comments
Novel drug and drug target for the treatment of addictive disorders characterized July 24, 2013 No Comments
RSS